An i n f a n t born t o a mother with hypercalcemia secondary t o m e t a s t a t i c b r e a s t cancer developed s e v e r e hypocalcemia during t h e f i r s t week of l i f e . Maternal calcium and phosphorous l e v e l s ranged from 14-17 mg/dl and 2-2.5 mg/dl, r e s p e c t i v e l y , p r i o r t o d e l i v e r y , and t h e i n f a n t ' s calcium l e v e l was 15.0 mg/dl a t birth During t h e f i r s t 9 days of l i f e t h e i n f a n t ' s serum Ca l e v e l decreased t o 4.8 mg/dl and P r o s e t o 8 . 4 mg/dl. The serum M g decreased t o 0.7 mg/dl.
An i n f a n t born t o a mother with hypercalcemia secondary t o m e t a s t a t i c b r e a s t cancer developed s e v e r e hypocalcemia during t h e f i r s t week of l i f e . Maternal calcium and phosphorous l e v e l s ranged from 14-17 mg/dl and 2-2.5 mg/dl, r e s p e c t i v e l y , p r i o r t o d e l i v e r y , and t h e i n f a n t ' s calcium l e v e l was 15.0 mg/dl a t birth During t h e f i r s t 9 days of l i f e t h e i n f a n t ' s serum Ca l e v e l decreased t o 4.8 mg/dl and P r o s e t o 8 . 4 mg/dl. The serum M g decreased t o 0.7 mg/dl.
Administration o f MgS04 intramuscularly r a i s e d t h e serum M g t o normal l e v e l s , but hypophosphaturia and hypocalcemia p e r s i s t e d . Administration of PTH was followed by return of Ca t o normal l e v e l s and an apparent i n c r e a s e i n P e x c r e t i o n . When PTH was stopped, serum Ca and M g again dec r e a s e d , but t h e phosphaturia p e r s i s t e d . Ca and M g l e v e l s r e t u r n e d t o normal spontaneously by t h e f o u r t h week of l i f e .
The hypocalcemia of t h i s i n f a n t supports t h e hypothesis of t r a n s i e n t neonatal hypoparathyroidism r e s u l t i n g from exposure t o r e l a t i v e l y high l e v e l s of maternal Ca i n u t e r o and c o n t r a d i c t s t h e theory t h a t i t i s r e l a t e d t o M g d e f i c i e n c y and end-organ unresponsiveness t o PTH.
HYPOCALCEMIA I N THALASSEMIA MAJOR. Alan R.Fleischman, John F. Rosen, Eva G. Radel, Joseph A. Kochen, (Spon. by Laurence Finberg), Albert E i n s t e i n Coll.Med.,Monte f i o r e Hospital and Medical Center, Dept.Ped., The Bronx, NY.
A t e n y e a r o l d p a t i e n t with thalassemia major who had been maintained on a chronic h y p e r t r a n s f u s i o n regimen f o r 8 y e a r s , presented with a tonic-clonic s e i z u r e . Admission l a b o r a t o r y d a t a included a serum l e v e l of t o t a l calcium of 5.7 mgldl, ionized calcium 2.08 mgldl, inorganic phosphorus 7.8 mgldl, and a l k a l i n e phosphatase 1.2 BLU. Although l i v e r f u n c t i o n was abnormal with e l e v a t e d transaminases, serum 25 hydroxyvitamin D l e v e l was normal a t 21.8 ng/ml. Concentration of immunoreactive parathyroid hormone was r e l a t i v e l y decreased a t 15 plEq/ml. S k e l e t a l radiographs were normal. Evaluation of o t h e r endocrine, r e n a l and g a s t r o i n t e s t i n a l f u n c t i o n s , were normal. Urinary e x c r e t i o n of calcium and CAMP were 43 mgI24 h r s . and 2.75 nmollmg c r e a t i n i n e l 24 h r s . r e s p e c t i v e l y , which a r e both markedly decreased from nor. mal. A l l s t u d i e s i n d i c a t e d hypoparathyroidism presumably due t o i r o n d e p o s i t i o n i n t h e gland. 1,25-dihydroxycholecalciferol i n an o r a l dose of 0.5-0.75 ugld, i n t h i s 22 kg c h i l d , c o r r e c t e d t h e hypocalcemia within 7 days of i n i t i a t i n g treatment. Serum ionized calcium l e v e l has remained normal f o r 100 treatment days w i t h no evidence of hypercalcemia o r h y p e r c a l c u r i a on a dose of 1.0-1.5 pgld of t h e hormone.
Four o t h e r c h i l d r e n maintained on chronic h y p e r t r a n s f u s i o n f o r thalassemia major had no evidence of hypocalcemia. This form of hypoparathyroidism i s recorded t o a l e r t t h e c l i n i c i a n t o a s i g n i f i c a n t complication and e f f e c t i v e new treatment plan i n thalassemia maior. T h i r t y -f i v e mothers w i t h previously documented d i a b e t e s and t h e i r i n f a n t s born a t term were s t u d i e d . T h i r t y i n f a n t s remained normocalcemic (serum ionized calcium > 3.0mgldl) and 5 i n f a n t s became hypocalcemic during t h e f i r s t 4 days of l i f e . Serum l e v e l s of 250HD from t h e s e d i a b e t i c mothers and t h e i r i n f a n t s were compared t o v a l u e s obtained from 30 normal term pregnancies. Serum l e v e l s of 250HD i n nglml a r e expressed a s mean ? 1SD:
N o r m a l .
DiabeticPreg.
Normocal . 11.9 + 3.1 Serum 250HD v a l u e s from normal term mothers and t h e i r neonates were g r e a t e r (p<O.OOl)than v a l u e s from d i a b e t i c mothers and t h e i r i n f a n t s . Serum l e v e l s of 250HD i n d i a b e t i c mothers and t h e i r inf a n t s who became hypocalcemic were s i g n i f i c a n t l y lower (~~0 . 0 1 ) t h a n v a l u e s from d i a b e t i c mothers and t h e i r i n f a n t s who remained normocalcemic. Serum 250HD l e v e l increased (p<0.05) i n both groups of i n f a n t s of d i a b e t i c mothers from day 1 t o day 14 of l i f e with l e v e l s i n t h e normocalcemic group remaining g r e a t e r t h a n t h e hypocalcemic group (p<0.05). A young boy with the severe form of osteogenesis imperfects was treated with NaF for 8 years (1 mg F/kg/d). The frequency of fractures decreased somewhat, but we could detect no gross improvement in bone density. Based on F bolance studies and analysis of a bone biopsy, his body F burden was estimated to be about 5 gm a t the end of the treatment period (age 14 yr).
These d a t a i n d i c a t e t h a t pregnancy i n d i a b e t i c s i s a s s o c i a t e d w i t h a low serum l e v e l of 250HD and suggest t h a t i n f a n t s born t o d i a b e t i c s with t h e lowest c o n c e n t r a t i o n s of 250HD a r e a t con-
NaF treatment was abruptly stopped, and during the next4 1/2 years a number of 24hr urine samples were analyzed for F. After the first few days, during which only 28 mg F were excreted, fluoride excretion declined exponentially: 10% of the body F burden was lost with a half-time of 5 months, 90% with one of 9 years. This latter value i s within the range observed'by others for the elimination of F and other "bone-seekers" (Sr, Pb, Ro) in normal subjects.
Since approximately 99% of body F is located in the mineral phase of bone this element can serve as a tracer for bone mineral. Based on the extended observations on our patient, it would appear that bone mineral turnover is normal in this disease.
